PE-425 Atorvastatin Reduces Serum Amyloid A in Metabolic Syndrome(Lipid Disorders 3 (IHD) : PE72)(Poster Session (English))
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2004-03-01
著者
-
Ghobrial Enas
Cairo Medical University Hospital Egypt Internal Medicine Department
-
Michael Yehia
Cairo Medical University Hospital Egypt, Internal Medicine Department
-
Foad Nadia
Cairo Medical University Hospital Egypt, Internal Medicine Department
-
Michael Yehia
Cairo Medical University Hospital Egypt Internal Medicine Department
-
Foad Nadia
Cairo Medical University Hospital Egypt Internal Medicine Department
関連論文
- PE-265 Assessment of Functional Capacity Following Percutaneous Metallic Mitral Valvotomy by Cardiopulmonary Exercise Testing(Valvular Heart Disease/Pericarditis/Cardiac Tumor 1 (M) : PE45)(Poster Session (English))
- Predictors of Regression of Mitral Regurgitation in Uremic Cardiomyopathy Following Kidney Transplantation(Valvular Heart Disease/Pericarditis/Cardiac Tumor 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PE-425 Atorvastatin Reduces Serum Amyloid A in Metabolic Syndrome(Lipid Disorders 3 (IHD) : PE72)(Poster Session (English))
- Prognostic Value of Progressive Impaired Renal Function in Patients with Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Triggering Factors for Acute Myocardial Infarction in Primary Antiphospholipid Syndrome(Infection/Inflammation/Immunity 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)